ITOC9 Committee

Conference President

  • Michael von Bergwelt
    (LMU, CCC, DKTK, Munich, Germany)

 

Chairman of the Scientific Committee

  • Sebastian Kobold
    (Ludwig-Maximilians-Universität, Munich, Germany)

  • Volkmar Nuessler
    (TZM, Munich, Germany)
     

Scientific Committee

  • Niroshana Anandasabapathy
    (Weill Cornell New York, NY, United States)

  • Paolo Ascierto
    (Istituto Nazionale Tumori, Naples, Italy)

  • Michael Bergmann 
    (Medical University Vienna, Austria)

  • Tanja D. de Gruijl  
    (Cancer Center Amsterdam, The Netherlands)

  • Rafal Dziadziuszko
    (Medical University of Gdańsk, Poland)

  • Ulrich Jäger
    (Medical University of Vienna, Austria)

  • Samir N. Khleif
    (Georgetown University Medical Center, United States)

  • Maciej Krzakowski
    (Oncology Centre, Maria Skłodowska-Curie Institute, Warsaw, Poland) 

  • Chong-Xian Pan
    (Harvard Medical School, Boston, MA, United States)

  • Sine Reker Hadrup
    (Technical University of Denmark, Experimental &Translational Immunology, Lyngby, Denmark)

  • Pedro Romero

  • (Translational Tumor Immunology Group, University of Lausanne, Switzerland)

  • José Saro
    (Vice-President, Global clinical Development, Adaptimmune Therapeutics, Abingdon, Oxfordshire, United Kingdom)

  • Barbara Seliger
    (Martin Luther University Halle-Wittenberg, Germany)

  • Maria Sibilia
    (Medical University of Vienna, Austria)

  • Wenru Song
    (Kira Pharmaceuticals, Arlington, United States)

  • Marion Subklewe
    (Ludwig-Maximilians-Universität, Munich, Germany)

  • Mario Sznol
    (Yale School of Medicine, New Haven, CT, United States)

  • Eric Tartour
    (Hopital Européen Georges-Pompidou, Paris, France)

  • Giorgio Trinchieri
    (Center for Cancer Research, NCI, NIH, Bethesda, MD, United States)

  • Lei Zheng
    (Johns Hopkins University, Baltimore, MD, United States)

  • Christoph Zielinski
    (Medical University of Vienna, Austria)